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Background:  The  indications  for  catheter  ablation  have  been  expanded  to include  persistent  atrial  ﬁbril-
lation  (AF)  to  enable  a high  degree  of  sinus  rhythm  maintenance.  We  occasionally  encounter  patients
undergoing  pacemaker  implantation  in whom  sick  sinus  syndrome  became  clinically  evident  after  abla-
tion.  This  study  investigated  whether  underlying  sinus  node  dysfunction  (SND)  during  persistent  AF  can
be predicted  before  deciding  the  indications  for ablation.
Methods  and  results:  In  total,  87  consecutive  patients  with  persistent  AF  who  underwent  catheter  ablation
between  January  2010  and July 2011  were  enrolled  in  the  study.  Nocturnal  polysomnography  as  well as
transthoracic  and  transesophageal  echocardiography  were  performed  in  all patients  before  ablation.  We
used  the  double  Lasso  catheter  and electroanatomical  mapping-guided  extensive  encircling  pulmonary
vein  isolation  (EEPVI)  method.  We  performed  electrophysiological  studies  after  EEPVI,  and  SND  was
deﬁned  as  a corrected  SN  recovery  time  of  ≥550  ms.  SND  was  detected  in  42  (48%)  patients  (SND  group);
the other  patients  showed  normal  sinus  node  function  (NSN  group).  The  apnea/hypopnea  index  (AHI)
was  signiﬁcantly  greater  in the SND  group  than  in  the  NSN  group  (25.7  ± 13  vs. 17.5  ±  11,  p =  0.002).
Multivariate  analysis  revealed  that  moderate  to severe  sleep-disordered  breathing  (deﬁned  as  AHI  ≥ 15)
was  an  independent  predictor  of  SND  after  catheter  ablation  for persistent  AF.
Conclusion:  The  results  suggest  that underlying  SND  in patients  with  persistent  AF can  be predicted  by
ed  br
2  Japevaluating  sleep-disorder
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. Introduction
Catheter ablation is an efﬁcient procedure for controlling drug-
efractory atrial ﬁbrillation (AF) [1].  The midterm results of catheter
blation for AF have been reported recently, and catheter ablation
as been considered useful for treating AF [2,3]. The indications for
atheter ablation have been expanded to include persistent AF, and
 high degree of sinus rhythm maintenance is enabled by additional
inear ablation and pulmonary vein isolation [4].  However, we  have
mplanted pacemakers in patients in whom sick sinus syndrome
ecame clinically evident after persistent AF ablation at a small but
elatively constant rate. Elvan et al. reported that chronic AF causes
inus node dysfunction (SND) in animal models and that the SN
unction slowly recovers after AF was terminated [5]. Some reports
ave indicated that patients with chronic AF develop SND after
ndergoing electrical cardioversion [6,7]. AF and SND are closely
∗ Corresponding author at: Department of Cardiology, Hiroshima University, 1-2-
 Kasumi, Minami-ku, Hiroshima 734-8551, Japan. Tel.: +81 82 257 5540;
ax: +81 82 257 5169.
E-mail address: chikaaki@me.com (C. Motoda).
914-5087/$ – see front matter © 2012 Japanese College of Cardiology. Published by Else
ttp://dx.doi.org/10.1016/j.jjcc.2012.05.004eathing  before  catheter  ablation.
anese  College  of  Cardiology.  Published  by  Elsevier  Ltd.  All rights  reserved.
related but we are unable to estimate SN function under contin-
ued persistent AF. If underlying SND during persistent AF can be
predicted, it would be useful for determining the necessity for per-
sistent AF ablation. There are some reports that atrial ﬁbrillation
becomes the causative factor of sleep respiratory disorder [8,9].
On another front, it was reported that sleep-disordered breathing
(SDB) contributes to the risk for atrial ﬁbrillation and sick sinus
syndrome [10]. These factors lead to a vicious cycle and worsen AF
and SDB. Therefore treatment intervention for AF by catheter abla-
tion is important to break the vicious cycle. Here, we  hypothesized
that persistent AF patients with SDB might have SND. The objec-
tive of this study was to investigate whether underlying SND can
be predicted prior to catheter ablation for persistent AF using the
apnea/hypopnea index (AHI).
2. Methods2.1. Study population
Catheter ablation for persistent atrial ﬁbrillation was performed
in a total of 103 patients at Hiroshima University Hospital between
vier Ltd. All rights reserved.
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anuary 2010 and July 2011. The type of AF was deﬁned according
o generally accepted guidelines [11]. From 103 patients, patients
ith signiﬁcant valvular disease requiring surgery, patients with
nderlying diseases such as thyroid dysfunction, patients with
eart failure, patients who were diagnosed with sick sinus syn-
rome in the past, and patients who had terminated AF by
harmacologic or electrical cardioversion were excluded and the
emaining 87 consecutive patients with persistent AF and long-
tanding persistent AF were registered in this study (mean age,
0.6 ± 8.7 years; 71 [81%] male). All antiarrhythmic agents were
enerally discontinued at least ﬁve half-lives before electro-
hysiologic studies [12]. Adequate oral anticoagulation therapy
international normalized ratio, 2.0–3.0) was administered not less
han 1 month before the procedure and was continued through-
ut the periprocedural period without interruption as previously
escribed [13]. Patients underwent transesophageal echocardiog-
aphy to exclude any left atrial (LA) thrombi; they also underwent
ransthoracic echocardiography and cardiac computed tomogra-
hy prior to ablation. This study was approved by the Institutional
eview Board at Hiroshima University Hospital. Written informed
onsent was obtained from all patients when they were recruited
o the study.
.2. Sleep study and polysomnography scoring
Nocturnal polysomnography (Alice 4; Philips Respironics GK,
okyo, Japan) was performed for all patients 1 day before the
atheter ablation; it included electroencephalography, electroocu-
ography, and submental and tibialis anterior electromyography
or sleep staging, according to a previous report [14]. Apnea was
eﬁned as the absence of airﬂow for >10 s despite persistent res-
iratory efforts. Hypopnea was deﬁned as a >50% reduction in the
mplitude of respiratory efforts for at least 10 s along with a fall
n arterial oxyhemoglobin saturation of at least 3%. The total dura-
ion of arterial desaturation was quantiﬁed as total time with an
rterial oxyhemoglobin saturation of <90%. The AHI was  deﬁned as
he number of episodes of apnea and hypopnea per hour of sleep.
he threshold for a diagnosis of sleep-disordered breathing (SDB)
as an AHI > 5, and that criterion was used to classify patients into
DB or non SDB groups. We  categorized sleep apnea using stan-
ard clinical cutoff points for severity (moderate to severe SDB:
HI ≥ 15) [15]. Therefore, the relationship between AHI and SND
as assessed by classifying patients on the basis of an AHI ≥ 15 in
he multivariate analysis.
.3. Cardiac parameter evaluation
We measured the end-systolic LA diameter, left ventric-
lar parameters, and ejection fraction with two-dimensional
2D) transthoracic echocardiography. LA appendage area and LA
ppendage ﬂow were measured by 2D transesophageal echocar-
iography 1 day before the catheter ablation.
.4. Catheter ablation
We  performed the double Lasso catheter and electroanatomi-
al mapping-guided extensive encircling pulmonary vein isolation
EEPVI) method. Brieﬂy, a 6-Fr decapolar catheter with 2–5–2 mm
nterelectrode spacing (St. Jude Medical, St. Paul, MN,  USA) was
ositioned in the coronary sinus. After transseptal catheterization,
wo 7-Fr decapolar Lasso catheters (Biosense Webster, Diamond
ar, CA, USA) were placed within the ipsilateral superior and
nferior pulmonary veins (PVs) guided by selective PV angiog-
aphy. After constructing three-dimensional electroanatomical
aps using a nonﬂuoroscopic navigation system (Carto, Biosense
ebster), continuous circumferential ablation lines were creatediology 60 (2012) 321–326
around the left- and right-sided PVs using a 3.5-mm tip irri-
gated catheter (ThermoCool, Biosense Webster) at a maximum
power of 30 W for 40 s at each site. Temperature was  limited to
50 ◦C. The EEPVI endpoint was  the creation of a bidirectional con-
duction block from LA to PVs. Subsequently, an additional linear
lesion connecting the superior aspects of the left and right upper
PV isolation lesions was  created. If AF was  still present after LA
ablation, external cardioversion was performed to restore sinus
rhythm. Finally, the cavotricuspid isthmus was  ablated with an
endpoint of a bidirectional conduction block using a 4.0-mm tip,
temperature-controlled, nonirrigated catheter (EPT; Boston Scien-
tiﬁc Corporation, Natick, MA,  USA) at a maximum power of 50 W
and a maximum electrode–tissue interface temperature of 60 ◦C.
Intravenous heparin was administered to maintain an activated
clotting time of 250–350 s during the procedure. The intraopera-
tive sedation depended on only thiamylal sodium just before EEPVI.
If sedation did not seem to be obtained or recovered, we supple-
mented with thiamylal sodium as needed and did not use other
sedatives.
2.5. Electrophysiological study and 24-h electrocardiographic
monitoring
After a stable sinus rhythm was established by catheter ablation,
quadripolar diagnostic catheters (St. Jude Medical) were placed at
the His bundle and at the superior right atrium. Subsequently, auto-
nomic blockade was induced by administering 0.04 mg/kg atropine
and 0.2 mg/kg propranolol, and the electrophysiological study was
performed within 1 h. AA, AH, and HV intervals were measured
with a baseline electrocardiogram. The sinus node recovery time
(SNRT), evaluated by 30-s burst pacing trains every 50 ms  from 600
to 300 ms,  was determined as the longest time from the stimulus
artifact to the earliest atrial activity. Corrected SNRT (CSNRT) was
deﬁned as the recovery interval in excess of the sinus cycle (max
SNRT-sinus cycle length) [16]. According to the 2006 guidelines for
clinical cardiac electrophysiological studies of the Japanese Circu-
lation Society and a previous report [17], SND was deﬁned as a
CSNRT of ≥550 ms.  AV node function was  evaluated by measur-
ing the AH interval, HV interval, the point of Wenckebach block
(AVN1:1 conduction) and the effective refractory period of the AV
node (AVNERP). The Wenckebach point of the AV node was  deter-
mined by increasing atrial pacing from just above the sinus rate
with increases of 10 impulses/min per 10 s. The anterograde AV
nodal effective refractory period (AVNERP) was  measured using an
eight-beat drive at a cycle length equal to the sinus cycle length
of 100 ms,  followed by a single premature atrial stimulus intro-
duced decrementally at 10-ms intervals. AVNERP was  deﬁned as
the longest coupled premature atrial stimuli interval that failed to
propagate to the His bundle. After catheter ablation, the subjects
wore 24-h electrocardiographic monitoring devices, from which
total beats, maximum heart rate, and minimum heart rate were
obtained. Heart rate variability such as low-frequency (LF) power,
high-frequency (HF) power, and the LF/HF ratio were also calcu-
lated using frequency domain analysis [18].
2.6. Statistical analysis
Continuous variables are presented as the mean ± SD, and the
Student’s t-test was used for comparison. Categorical variables
are presented as the number of data and percent, and compared
employing the 2 test. Multivariate analysis was  used to deter-
mine the independent risk factors for SND. Potential predictors
with p-values < 0.20 on the univariate analysis were included in a
multivariate logistic regression analysis. Odds ratios and 95% conﬁ-
dence intervals were calculated. p-values of <0.05 were regarded as
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Table  1
Patient baseline characteristics and sinus node dysfunction.
NSN (n = 45,
52%)
SND (n = 42,
48%)
p-Value
Age (years) 58 ± 9.4 62 ± 7.6 0.04
Male (%) 85 72 0.15
Structural heart disease (%) 27 25 0.85
Hypertension (%) 41 36 0.63
Hyperlipidemia (%) 35.5 40.9 0.69
Diabetes mellitus (%) 70 53 0.1
AF  duration (months) 70 ± 12 67 ± 12 0.87
ACE  or ARB (%) 34.1 41.6 0.5
HANP (pg/ml) 74.8 ± 70 70 ± 30 0.76
CRP  pre ablation (mg/dl) 0.12 ± 0.06 0.12 ± 0.08 0.95
Anti-arrhythmic agents before catheter ablation
Class Ia/Ib/Ic (%) 0/4.9/4.9 2.7/2.8/2.8 0.2/0.6/0.6
Class II/III/IV (%) 22/25/22 27/33/23 0.6/0.4/0/9
Cardiac structural parameters
LAA area (cm2) 5.7 ± 2.0 5.7 ± 1.8 0.89
LAA  ﬂow (m/s) 0.45 ± 0.18 0.39 ± 0.18 0.17
LVDd (mm) 47.3 ± 5.0 46.9 ± 3.7 0.69
LVDs (mm)  32.6 ± 4.1 32.6 ± 4.1 0.98
LA  diameter (mm)  41.4 ± 5.0 41.6 ± 4 0.83
Ejection fraction (%) 56.1 ± 5.7 57.6 ± 6.4 0.28
Values are presented as mean or percentage ± SD. ACE, angiotensin-converting
enzyme; AF, atrial ﬁbrillation; ARB, angiotensin II receptor blocker; AHI,
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with moderate to severe SDB was signiﬁcantly higher than that
without (53.9% vs. 23.7%; p = 0.006). C-reactive protein levels in
patients with moderate to severe SDB were also higher than those
without (0.15 ± 0.04 vs. 0.007 ± 0.01; p = 0.03). LA diameters in
Table 3
Catheter ablation and electrophysiological study.
NSN (n = 45, 52%) SND (n = 42, 48%) p-Valuepnea/hypopnea index; SND, sinus node dysfunction; NSN, normal sinus node; LAA,
eft atrial appendage; LVDd, left ventricular dimension diastolic; LVDs, left ventric-
lar  dimension systolic.
igniﬁcant. All statistical analyses were performed using JMP  ver-
ion 8.0.2 (SAS Institute, Cary, NC, USA).
. Results
In total, 42 patients (48%) had SND (SND group), and the remain-
ng patients had normal sinus node function (NSN group). Table 1
hows the patient characteristics. Age in the SND group was  sig-
iﬁcantly higher than that in the NSN group (62 ± 7.6 vs. 58 ± 9.4;
 = 0.04). The other parameters of the patient characteristics were
imilar in both groups. No difference was observed in the antiar-
hythmic agents between the SND and NSN groups pre catheter
blation. No signiﬁcant differences were observed for the car-
iac structural parameters. The sleep disorders of the all cases
etected in preoperative polysomnography were obstruction type.
HI and arousal index were signiﬁcantly higher and SpO2 was sig-
iﬁcantly lower in the SND group than in the NSN group (AHI:
5.7 ± 12.7 vs. 17.5 ± 11.4; p = 0.0022; arousal index: 23.3 ± 6.8
s. 34.4 ± 10.1; p = 0.032; SpO2: 83 ± 1.4 vs. 87.9 ± 1.6; p = 0.025)
Table 2). There was a positive correlation between AHI and CSNRT
R: 0.51; p < 0.0001; Fig. 1). Table 3 shows the ablation procedure
nd electrophysiological parameters after catheter ablation. SNRT
f the SND group was signiﬁcantly longer than that in the NSN
roup (1874 ± 790 ms  vs. 1218 ± 250 ms,  respectively; p < 0.0001).
SNRT was also longer in the SND group than in the NSN group
able 2
leep study and polysomnography score.
NSN (n = 45, 52%) SND (n = 42, 48%) p-Value
AHI 17.5 ± 11.4 25.7 ± 12.7 0.0022
Apnea index 16.7 ± 15.3 23.7 ± 11 0.082
Hypopnea index 16.5 ± 15.2 23.8 ± 11.1 0.067
Mean SpO2 (%) 97 ± 2.4 96 ± 2.3 0.27
Minimum SpO2 (%) 87.9 ± 1.6 83 ± 1.4 0.025
Sleep time (min) 517 ± 78 497 ± 52 0.29
Arousal index 23.3 ± 6.8 34.4 ± 10.1 0.032
OSA (%) 100 100
ND, sinus node dysfunction; NSN, normal sinus node; AHI, apnea/hypopnea index;
SA,  obstructive sleep apnea.Fig. 1. Correlation between apnea/hypopnea index (AHI) and corrected sinus node
recovery time (CSNRT). There was a positive correlation between AHI and CSNRT.
(986 ± 109 ms  vs. 395 ± 112 ms  in the SND and NSN groups, respec-
tively; p < 0.0001). No signiﬁcant differences were observed for the
AH interval, HV interval, the point of Wenckebach block (AVN1:1
conduction), or AVNERP between the groups. There was  no dif-
ference in the ablation procedure between either group. The 24-h
electrocardiographic monitoring after catheter ablation revealed
that total beats in the SND group were signiﬁcantly lower than that
in the NSN group (90,639 ± 15,806 vs. 99,357 ± 16,595; p = 0.025)
(Fig. 2). Minimum heart rate and average heart rate during night
time in the SND group were also lower than those in the NSN group
(minimum heart rate: 63 ± 9.3 vs. 68 ± 10 bpm; p = 0.038; average
heart rate during night time: 68 ± 8.1 vs. 78 ± 10 bpm; p = 0.032).
No difference was  observed in the LF/HF ratio between the SND
and NSN groups (Table 4). A multivariate analysis showed that
moderate to severe SDB (AHI ≥ 15) was an independent predic-
tor of SND after catheter ablation for persistent AF (Table 5). Two
patients required temporary pacemakers (0.023%) after catheter
ablation, and one needed a permanent pacemaker. The average
AHI of all patients (n = 87) was  21.2 ± 12.6, and 45 patients (51%)
had moderate to severe SDB (AHI ≥ 15). Hypertension in patientsSNRT (ms) 1218 ± 250 1874 ± 790 <0.0001
A-A  interval (ms) 820 ± 184 859 ± 137 0.31
CSNRT (ms) 395 ± 112 986 ± 109 <0.0001
AVN1:1 conduction (bpm) 156 ± 24 146 ± 25 0.07
AH  interval (ms) 86 ± 19 94 ± 29 0.20
HV  interval (ms) 43 ± 9.1 45 ± 15 0.34
AVN–ERP (ms) 296 ± 49 306 ± 69 0.59
LPV  ablation (min) 23.9 ± 15.2 22.6 ± 10.6 0.81
RPV  ablation (min) 26.9 ± 14.6 26.5 ± 19.8 0.93
PVI  time (min) 63.9 ± 22.5 59.9 ± 24.2 0.54
Fluoroscopy time (min) 64.7 ± 17.6 60.4 ± 13.6 0.35
Radiation dosage (mgy) 1462 ± 738 1929 ± 1270 0.12
Ablation points (points) 95.8 ± 33.7 89.8 ± 36.3 0.53
Thiamylal sodium (mg) 476.5 ± 162 517.5 ± 222 0.33
Frequency of EC (J) 108.9 ± 27.3 106 ± 21.9 0.67
Number of EC 1.39 ± 0.62 1.52 ± 1.32 0.65
Values are presented as mean or percentage ± SD. SNRT, sinus node recovery time;
CSNRT, corrected sinus node recovery time; AVN1:1, the point of the Wenckebach
block; AVN-ERP, the effective AV node refractory period; SND, sinus node dysfunc-
tion; NSN, normal sinus node; EC, electrical cardioversion.
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Fig. 2. Total heart beats after catheter ablation. The 24-h electrocardiographic mon-
itoring after catheter ablation revealed that total beats in the sinus node dysfunction
(SND) group were signiﬁcantly lower than that in the normal sinus node function
(NSN) group.
Table 4
Results of the 24-h electrocardiographic monitoring after catheter ablation.
NSN (n = 45, 52%) SND (n = 42, 48%) p-Value
Total beats (beats) 99,357 ± 16,595 90,639 ± 15,806 0.025
Max  HR (bpm) 113 ± 16 107 ± 17 0.14
Min  HR (bpm) 68 ± 10 63 ± 9.3 0.038
Average HR (all day) 83 ± 8.2 77 ± 7.5 0.091
Average HR (day time) 89 ± 11 86 ± 7.4 0.37
Average HR (night time) 78 ± 10 68 ± 8.1 0.032
LF  380 ± 158 508 ± 183 0.60
HF 715 ±  341 885 ± 407 0.75
LF/HF 1.58 ± 1.8 1.09 ± 1.0 0.18
Values are presented as mean or percentage ± SD. HR, heart rate; LF, low frequency;
H
p
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ridge of left pulmonary vein (LPV). In our study, we performed only
EEPVI without additional ganglionated plexus ablation, and there
T
P
U
iF, high frequency; SND, sinus node dysfunction; NSN, normal sinus node.
atients with moderate to severe SDB were larger than those with-
ut (42.5 ± 4.7 vs. 40.4 ± 4.2; p = 0.04). Heart rate variability was
imilar in patients with and without moderate to severe SDB. In our
tudy, two patients (0.023%) required temporary pacemakers after
atheter ablation, and one of them needed a permanent pacemaker.
he CSNRT and total beats 24-h electrocardiographic monitoring of
he patient with a permanent pacemaker were 2626 ms  and 66,302
eats, respectively.
able 5
redictors of sinus node dysfunction after catheter ablation.
Uni 
OR 95% CI 
Age (>60 years) 1.97 0.83–4.7 
AF  duration (>36 months) 1.4 0.55–3.3 
Structural heart disease 0.91 0.33–2.53 
Men  0.45 0.14–1.38 
Obesity (BMI > 24) 1.9 0.62–5.6 
Moderate to severe SDB 4.8 1.93–12.1 
Hypertension 0.79 0.31–2.0 
Diabetes mellitus 2.1 0.85–5.5 
ARB  or ACE 0.65 0.17–2.5 
LAA area (>5.0 cm2) 0.98 0.37–2.7 
LAA ﬂow (<0.3 m/s) 1.6 0.55–4.4 
LA  dimension (>40 mm) 1.0 0.32–3.2 
Ejection fraction (<55%) 1.7 0.63–4.4 
CRP preablation (>0.02 mg/dl) 1.2 0.40–3.3 
ni, univariate analysis; Multi, multivariate logistic regression analysis; OR, odds ratio; C
nhibitor; ARB, angiotensin II receptor blocker; LAA, left atrial appendage; LA, left atrial; Ciology 60 (2012) 321–326
4. Discussion
In this study, 42 patients (48%) showed SND after catheter abla-
tion for persistent AF. We  found that SDB was an independent
predictor of underlying SND in patients with persistent AF who
underwent catheter ablation.
Several reports have indicated that various factors evoked by
SDB cause AF. Hypoxemia and hypercapnia have direct adverse
effects on cardiac electrical stability and are arrhythmogenic sub-
strates [19,20]. Patients with SDB are susceptible to AF with
increased sympathetic nerve activation during sleep [21]. The
forceful ventilatory efforts against upper airway obstruction during
apnea result in sympathetic vasoconstriction and increased blood
pressure. Increases in blood pressure coupled with the increased
afterload resulting from sleep apnea-induced vasoconstriction may
contribute to an increase in LA dimensions [22]. In addition, the
severity of SDB is independently associated with elevated mark-
ers of systemic inﬂammation [23], and C-reactive protein levels
are directly associated with the increasing burden of AF [24]. In
chronic phase, these acute structural changes may  promote AF by
triggering stretch-activated atrial ion channels [25]. In our study, as
previously reported, the percentage of patients with moderate to
severe SDB who had hypertension and elevated C-reactive protein
levels was  signiﬁcantly higher than those without. LA diameters
in patients with moderate to severe SDB were larger than those
without.
Some reports have also indicated that atrial remodeling caused
by AF leads to susceptibility to SND. In a study including 12 patients
with chronic lone AF, Kumagai et al. [6] assessed SN function on the
day after electrical conversion to sinus rhythm. They found that the
mean CSNRT of the patients was signiﬁcantly longer than that of
controls and was  abnormal in nine (75%) patients. Similarly, Man-
ios et al. [7] reported that abnormal CSNRT was  found in 10/37
(27%) patients with chronic AF after cardioversion to sinus rhythm.
In our study, we  performed the electrophysiological study within
1 h after the ablation in patients who  achieved sinus rhythm by
ablation, and SND was  found in 42/87 (48%) of patients with per-
sistent AF. In addition, the total number of heart beats from 24-h
electrocardiographic monitoring was  signiﬁcantly lower in the SND
group than in the NSN group at 24 h after the ablation.
We sometimes experience tachycardia during the ablation of
right pulmonary vein (RPV) and bradycardia during the ablation ofwas no difference in the procedure in all the cases. As for the EEPVI
in the present study, more than 20% decrease in heart rate during
Multi
p-Value OR 95% CI p-Value
0.12 1.2 0.44–3.5 0.69
0.51
0.86
0.16 0.37 0.1–1.35 0.13
0.26
0.001 3.8 1.32–11 0.013
0.63
0.11 1.3 0.46–4.0 0.57
0.53
0.98
0.41
0.98
0.30
0.79
I, conﬁdence interval; BMI, body mass index; ACE, angiotensin-converting enzyme
RP, C-reactive protein.
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[
[
[
[
[C. Motoda et al. / Journal o
blation of LPV was found in 22% of NSN group and in 18% of SND
roup (p = 0.13). And, more than 20% increase in heart rate during
blation of RPV was found in 18% of NSN group and in 12% of SND
roup (p = 0.15). The alternation of heart rate during the EEPVI was
imilar in the two groups. Additionally, LF power, HF power, and the
F/HF ratio in 24-h electrocardiographic monitoring after ablation
ere also similar in the two groups. In general, sinus node function
an be assessed by overdrive suppression test during electrophys-
ological study and also by 24 h electrocardiographic monitoring.
n this study, SNRT (CSNRT) was measured after pharmacologic
enervation during catheter ablation procedure, whereas 24 h elec-
rocardiography was recorded after catheter ablation. Then, we
annot deny the inﬂuence of denervation to the ganglion plexi or
heir ﬁbers by the EEPVI about the 24 h electrocardiography. In our
tudy, Min  HR, total beats of 24 h electrocardiography recording
nd average HR during night time were lower in patients with SND
han those in patients with NSD.
AF can lead to changes in connexin patterns, myocyte cellu-
ar substructure, interstitial ﬁbrosis, and apoptotic atrial myocyte
eath [26]. These structural changes may  also be the result of
ND. In our study, no signiﬁcant differences in LA diameter were
bserved between patients with and without SND. The conduction
f AV node tended to deteriorate in patients with SND. Antiar-
hythmic drugs were discontinued preoperatively. The structural
emodeling was also likely to have an adverse impact on AV node
onduction.
On another front, it was reported that SDB itself causes deterio-
ation in SN function [10]. SND may  easily cause AF and vice versa,
s discussed above. Thus, the possibility that SND is caused by SAS
nd that AF is caused by SND may  be valid. These factors such as
DB, SND, and AF may  lead to a vicious cycle and worsen the AF and
DB. Therefore, treatment intervention for AF by catheter ablation
s very important to break out of the vicious cycle. By expand-
ng catheter ablation for persistent AF, there may  be cases that
equire additional treatment for bradycardia, but unexpected SND
fter catheter ablation may  increase. In this study, we  hypothesized
hat persistent AF patients with SDB might have SND. However, it
s difﬁcult to evaluate SN function in patients with persistent AF
efore conversion to sinus rhythm. The objective of this study was
o investigate whether underlying SND can be predicted prior to
atheter ablation for persistent AF using the AHI. As a result, SND
as found in signiﬁcantly more cases of the moderate to severe
DB group than that in the NSN group in the electrophysiological
tudies after catheter ablation for persistent AF. Our results sug-
ested that the AF patients complicated with SDB were susceptible
o SND. Then, we had better intervene in the SDB before and after AF
blation. The improvement of SDB by continuous positive airway
ressure or assisted ventilation may  bring beneﬁcial change to SND
nd avoid pacemaker implantation and we positively become able
o use an antiarrhythmic drug after the AF ablation. The AF ablation
nd treatment intervention for the SDB before and after the proce-
ure may  be a new hybrid therapy for AF and there is the potential
or improving the long-term outcome for sinus node maintenance
fter the AF ablation.
. Limitations
There are some limitations in this study. We  evaluated CSNRT
mmediately after ablation. AF ablation inﬂuenced autonomic tone.
herefore, we evaluated electrophysiological parameters after an
utonomic block. In addition, heart rate variability using the fre-
uency domain analysis of 24 h electrocardiographic monitoring
as similar in patients with and without SND. The autonomic mod-
ﬁcation by the pulmonary vein isolation itself may  be a study
imitation of this study. We  only used thiamylal sodium as an
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anesthetic for the catheter ablation. Effects of the thiamylal sodium
on the autonomic nervous system and atrial electrophysiology can-
not be ruled out, but we have used this drug in subjects under the
same conditions. Additionally, total doses of sedative agent were
similar in both groups. In our study, two patients (0.023%) required
temporary pacemakers after catheter ablation, and one needed a
permanent pacemaker. Patients who required a permanent or tem-
porary pacemaker had AHI ≥ 15. Because of the small number of
subjects enrolled in this study, we  were unable to identify patients
who needed a permanent pacemaker from those who  did not.
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